SUNOSI is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Axsome Therapeutics, Inc.. The primary component is Solriamfetol.
Product ID | 81968-351_362f206b-73e7-4009-8c34-5a9df55679ab |
NDC | 81968-351 |
Product Type | Human Prescription Drug |
Proprietary Name | SUNOSI |
Generic Name | Solriamfetol |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-06-18 |
Marketing Category | NDA / |
Application Number | NDA211230 |
Labeler Name | Axsome Therapeutics, Inc. |
Substance Name | SOLRIAMFETOL |
Active Ingredient Strength | 150 mg/1 |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-06-02 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
68727-350 | SUNOSI | solriamfetol |
68727-351 | SUNOSI | solriamfetol |
81968-350 | SUNOSI | solriamfetol |
81968-351 | SUNOSI | solriamfetol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SUNOSI 87151190 5857817 Live/Registered |
Jazz Pharmaceuticals, Inc. 2016-08-25 |